Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10

Engler, D.B.; Reuter, S.; Wijck, Y. van; Urban, S.; Kyburz, A.; Maxeiner, J.; ... ; Muller, A. (2014)

Article / Letter to editor

• bacterial immunomodulation
• allergy and asthma prevention
• tolerogenic dendritic cells
• bacterial persistence determinants

• All authors: Engler, D.B.; Reuter, S.; Wijck, Y. van; Urban, S.; Kyburz, A.; Maxeiner, J.; Martin, H.; Yogev, N.; Waisman, A.; Gerhard, M.; Cover, T.L.; Taube, C.; Muller, A.
• Date: 2014-08-12
• Journal: Proceedings of the National Academy of Sciences
• Volume: 111
• Issue: 32
• Pages: 11810 - 11815
• DOI: doi:10.1073/pnas.1410579111